Said Saim

Chief Technology Officer at EyePoint Pharmaceuticals

Dr. Saim has more than 25 years of product development experience. He most recently served as Vice President, Pharmaceutical Development at Collegium Pharmaceutical, where his responsibilities included managing formulation development, clinical trial manufacturing, and commercial manufacturing for immediate, delayed, and controlled release dosage forms. Prior to joining Collegium, Dr. Saim served as Senior Principal Scientist at Boehringer Ingelheim Pharmaceuticals, Inc., where he led a team of engineers and scientists in charge of process development, scale-up, and technology transfer of North American products. Prior to joining Boehringer Ingelheim, Dr. Saim was Assistant Research Professor at the Higuchi Biosciences Center for Drug Delivery Research. Dr. Saim has published 22 papers in engineering and science journals and holds 18 patents. Dr. Saim earned a Ph.D. in chemical engineering from the University of Kansas.

Links

Previous companies

Boehringer Ingelheim logo

Org chart

Sign up to view 1 direct report

Get started